查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1943706

透析中心市場 - 全球產業規模、佔有率、趨勢、競爭格局、機會及預測（按所有權、透析類型、服務、地區和競爭情況分類），2021-2031年

Dialysis Center Market - Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, Segmented By Ownership, By Type of Dialysis, By Service, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球透析中心市場預計將從 2025 年的 1,102.5 億美元成長到 2031 年的 1,478.3 億美元，年複合成長率為 5.01%。

這些專業設施對於為末期腎功能衰竭患者提供腎臟替代療法（例如血液透析和腹膜透析）至關重要。市場成長趨勢的主要驅動力是全球慢性腎臟病，而人口老化以及糖尿病和高血壓發病率的飆升是造成這一趨勢的重要因素。這導致迫切需要建立持久的長期照護基礎設施，以滿足日益成長的患者需求。根據美國國家腎臟基金會的報告顯示，到2024年，美國預計將有3,550萬成年人患有慢性腎臟病，凸顯了提供便利腎臟護理服務的緊迫性。

市場概覽
預測期 2027-2031
市場規模：2025年 1102.5億美元
市場規模：2031年 1478.3億美元
複合年成長率：2026-2031年 5.01%
成長最快的細分市場 血液透析
最大的市場 北美洲

儘管市場需求旺盛，但由於建立和維護透析中心的成本高昂，市場擴張面臨許多挑戰。除了需要大量資金購買專用設備、水質淨化系統和醫療耗材外，合格的腎臟科護理師和技師在全球範圍內也面臨短缺，醫療服務提供者難以招募足夠的人員。公共醫療體系中停滯不前且複雜的薪資結構進一步加劇了這些財務壓力，造成了嚴峻的經濟環境。這些營運限制可能會阻礙新設施的建設，並限制經濟低度開發地區關鍵服務的可近性。

市場促進因素

推動透析中心市場發展的主要因素是全球慢性腎臟病和末期腎功能衰竭，這主要是由於糖尿病和高血壓的日益普遍。隨著這些文明病相關疾病的日益流行，腎功能下降速度加快，對腎臟替代療法的需求持續增加。這一趨勢導致依賴血液透析和腹膜透析維持生命的患者數量不斷增加。代謝性疾病與腎衰竭之間的關聯至關重要，需要大規模的基礎設施建設來應對不斷成長的病例數。例如，美國國家腎臟基金會於2024年5月發布的一份報告估計，大約三分之一的糖尿病成人患者會患上慢性腎臟病，這凸顯了合併症對腎臟健康的嚴重影響以及由此產生的對專業護理的需求。

此外，腎臟捐贈者嚴重短缺，導致透析服務亟需擴充。許多患者依賴透析服務，或將其作為等待移植的臨時措施，或作為永久解決方案。器官移植需求患者數量與捐贈器官供應有限之間存在巨大缺口，迫使患者長期接受透析治療，加劇了現有透析設施的使用。根據聯合國器官移植網路（UNOS）的數據，截至2025年1月，美國約有9萬人等待腎臟移植，凸顯了根治性治療的瓶頸。這一缺口確保了醫療服務提供者擁有穩定的患者群體，DaVita公司於2025年2月發布的數據也印證了這一點（截至2024年底，該公司在全球為約281,100名患者提供服務）。

市場挑戰

由於建立和營運透析中心會帶來沉重的財務負擔，透析中心市場的擴張面臨嚴峻的挑戰。當前充滿挑戰的經濟環境，以及對專用設備和水處理系統的高資本投資，持續擠壓著業者的利潤空間。這種財務不穩定主要是由於不斷上漲的營運成本與公共醫療保險機構固定報銷率之間的差距日益擴大。當治療成本超過每次治療的收入時，機構將被迫暫停擴張，甚至可能被迫關閉經濟低度開發地區的診所，從而限制市場准入。

由於勞動力嚴重短缺導致人事費用人為上漲，加劇了這種經濟壓力。為了吸引和留住所需的腎內科護理師和技師，醫療機構必須支付更高的工資，但這些增加的成本並未被收入的成長所抵消。根據透析患者公民協會的數據，到2024年，醫療機構的人事費用在過去兩年中增加了9.7%，而聯邦醫療保險（Medicare）的報銷率僅增加了1.7%。這種不永續的財務差距阻礙了醫療機構對新基礎設施的投資，並抑制了全球市場的整體發展。

市場趨勢

透析產業正經歷重大變革時期，從計量型模式轉向基於價值的醫療服務模式，這從根本上改變了其營運策略。透析服務提供者越來越注重患者的治療效果，例如減少再入院率和延緩疾病進展，而不是僅僅追求治療量。這種轉變推動了整合式醫療合約的普及，在這種合約下，醫療機構承擔患者整體健康的財務風險，這要求他們與腎臟科醫生和基層醫療醫生更緊密地合作。例如，DaVita 在其於 2025 年 2 月發布的「2024 年第四季財務表現」報告中指出，截至 2024 年底，該公司將根據基於風險的整合式醫療合約管理約 70,400 名患者，這凸顯了大型服務提供者對這些基於績效的支付模式的快速採用。

同時，居家透析培訓和支援的擴展正在重新定義傳統診所的角色和物理結構。透析中心正在轉型為教育和後勤樞紐，為選擇腹膜透析和居家血液透析的患者提供必要的培訓、設備和遠端監測。這一趨勢使醫療機構能夠透過管理費和培訓費獲得收入，同時滿足患者日益成長的自主性和生活方式柔軟性的需求。根據美國腎臟數據系統於2025年1月發布的《2024年數據報告》，約有15%的新發和現有末期腎功能衰竭患者正在接受居家治療方法，這使得他們對醫療機構支持這種分散式護理模式的依賴性日益增強。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球透析中心市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依所有權類型（獨立運作與醫院附屬運作）
    • 依透析類型（血液透析和腹膜透析）
    • 依服務類型（院內/住院 vs.門診病人）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美透析中心市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲透析中心市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區透析中心市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲透析中心市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲透析中心市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球透析中心市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Fresenius Medical Care AG & Co. KGaA
  • DaVita Inc.
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Nipro Corporation
  • Renal Ventures Management, LLC
  • US Renal Care, Inc.
  • Dialysis Clinics, Inc.
  • MEDICARE Health Partners
  • Asahi Kasei Corporation

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 8026

The Global Dialysis Center Market is projected to expand from USD 110.25 Billion in 2025 to USD 147.83 Billion by 2031, reflecting a compound annual growth rate of 5.01%. These specialized facilities are essential for providing renal replacement therapies, such as hemodialysis and peritoneal dialysis, to patients suffering from end-stage renal disease. The market's upward trajectory is primarily caused by the increasing global prevalence of chronic kidney conditions, a trend heavily influenced by aging demographics and the surging rates of diabetes and hypertension. Consequently, there is a pressing need for durable, long-term care infrastructure to accommodate the rising patient numbers. As reported by the National Kidney Foundation, an estimated 35.5 million adults in the United States were living with chronic kidney disease in 2024, emphasizing the urgent demand for accessible renal care services.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 110.25 Billion
Market Size 2031USD 147.83 Billion
CAGR 2026-20315.01%
Fastest Growing SegmentHemodialysis
Largest MarketNorth America

Despite this demand, market expansion faces significant hurdles due to the high costs involved in establishing and maintaining dialysis centers. Providers grapple with the substantial capital required for specialized equipment, water purification systems, and medical consumables, alongside a global scarcity of qualified nephrology nurses and technicians. These financial pressures are often exacerbated by stagnant or complicated reimbursement structures within public health systems, creating a challenging economic environment. Such operational constraints can hinder the development of new facilities and restrict the availability of critical services in economically constrained regions.

Market Driver

The primary force driving the dialysis center market is the growing global incidence of chronic kidney disease and end-stage renal disease, which is largely propelled by increasing rates of diabetes and hypertension. As these lifestyle-associated conditions become more common, they hasten the decline of kidney function, resulting in a persistent demand for renal replacement therapies. This trend ensures a steady stream of patients who depend on life-sustaining hemodialysis or peritoneal dialysis. The link between metabolic disorders and kidney failure is significant, requiring extensive infrastructure to manage the rising caseload. For instance, the National Kidney Foundation reported in May 2024 that approximately one in three adults with diabetes was estimated to have chronic kidney disease, highlighting the profound effect of comorbidities on renal health and the subsequent need for specialized care.

Furthermore, the critical scarcity of kidney donors mandates the expansion of dialysis services, as many patients must rely on these centers either as a temporary measure while awaiting a transplant or as a permanent solution. The vast gap between the number of patients needing organ replacement and the limited supply of donor organs compels individuals to stay on dialysis for prolonged periods, thereby increasing the utilization of existing facilities. According to the United Network for Organ Sharing, nearly 90,000 individuals in the United States were on the kidney transplant waiting list in January 2025, illustrating the bottleneck in curative treatments. This gap ensures consistent patient volumes for providers, as evidenced by DaVita Inc., which reported in February 2025 that it served approximately 281,100 patients worldwide by the end of 2024.

Market Challenge

The expansion of the dialysis center market is severely threatened by the significant financial burdens involved in setting up and running facilities. Providers encounter a rigid economic environment characterized by high capital expenditures for specialized machinery and water treatment systems, which continuously squeeze operating margins. This financial precarity stems largely from the growing gap between escalating operational costs and flat reimbursement rates from public health payers. When the expense of providing treatment outstrips the revenue earned per session, organizations are compelled to pause capacity growth and may even be forced to shut down clinics in economically disadvantaged areas, thereby restricting market access.

This economic strain is intensified by severe workforce shortages that artificially drive up labor expenses. To attract and keep necessary nephrology nurses and technicians, facilities are required to pay higher wages; however, these increased costs are not met with proportional revenue increases. Data from Dialysis Patient Citizens indicates that in 2024, labor costs for providers rose by 9.7% over the previous two years, while Medicare reimbursement rates increased by only 1.7%. This unsustainable financial disparity hinders providers from investing in new infrastructure and impedes the overall development of the global market.

Market Trends

The industry is undergoing a significant transformation as it moves from traditional fee-for-service models toward value-based healthcare delivery, fundamentally altering operational strategies. Dialysis providers are increasingly motivated to focus on patient outcomes, such as minimizing hospital readmissions and slowing disease progression, rather than simply increasing treatment volumes. This evolution supports the adoption of integrated care contracts where centers accept financial risk for a patient's overall health, requiring closer collaboration with nephrologists and primary care providers. As an example of this shift, DaVita Inc. reported in its '4th Quarter 2024 Results' in February 2025 that it was managing roughly 70,400 patients under risk-based integrated care arrangements by the end of 2024, highlighting the speed at which major providers are embracing these outcome-focused payment models.

Simultaneously, the growth of home dialysis training and support is redefining the role and physical structure of traditional clinics. Dialysis centers are evolving into educational and logistical hubs that supply the necessary training, equipment, and remote monitoring for patients who choose peritoneal dialysis or home hemodialysis. This trend enables facilities to generate revenue through management fees and training reimbursements while satisfying the rising patient desire for greater autonomy and lifestyle flexibility. According to the '2024 Annual Data Report' released by the United States Renal Data System in January 2025, approximately 15% of new and existing end-stage renal disease patients were using home-based modalities, demonstrating the growing reliance on centers to support this decentralized approach to care.

Key Market Players

  • Fresenius Medical Care AG & Co. KGaA
  • DaVita Inc.
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Nipro Corporation
  • Renal Ventures Management, LLC
  • U.S. Renal Care, Inc.
  • Dialysis Clinics, Inc.
  • MEDICARE Health Partners
  • Asahi Kasei Corporation

Report Scope

In this report, the Global Dialysis Center Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Dialysis Center Market, By Ownership

  • Standalone v/s Hospital-Based

Dialysis Center Market, By Type of Dialysis

  • Hemodialysis v/s Peritoneal Dialysis

Dialysis Center Market, By Service

  • In-Center/Inpatient v/s Outpatient

Dialysis Center Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Dialysis Center Market.

Available Customizations:

Global Dialysis Center Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Dialysis Center Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Ownership (Standalone v/s Hospital-Based)
    • 5.2.2. By Type of Dialysis (Hemodialysis v/s Peritoneal Dialysis)
    • 5.2.3. By Service (In-Center/Inpatient v/s Outpatient)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Dialysis Center Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Ownership
    • 6.2.2. By Type of Dialysis
    • 6.2.3. By Service
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Dialysis Center Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Ownership
        • 6.3.1.2.2. By Type of Dialysis
        • 6.3.1.2.3. By Service
    • 6.3.2. Canada Dialysis Center Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Ownership
        • 6.3.2.2.2. By Type of Dialysis
        • 6.3.2.2.3. By Service
    • 6.3.3. Mexico Dialysis Center Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Ownership
        • 6.3.3.2.2. By Type of Dialysis
        • 6.3.3.2.3. By Service

7. Europe Dialysis Center Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Ownership
    • 7.2.2. By Type of Dialysis
    • 7.2.3. By Service
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Dialysis Center Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Ownership
        • 7.3.1.2.2. By Type of Dialysis
        • 7.3.1.2.3. By Service
    • 7.3.2. France Dialysis Center Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Ownership
        • 7.3.2.2.2. By Type of Dialysis
        • 7.3.2.2.3. By Service
    • 7.3.3. United Kingdom Dialysis Center Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Ownership
        • 7.3.3.2.2. By Type of Dialysis
        • 7.3.3.2.3. By Service
    • 7.3.4. Italy Dialysis Center Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Ownership
        • 7.3.4.2.2. By Type of Dialysis
        • 7.3.4.2.3. By Service
    • 7.3.5. Spain Dialysis Center Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Ownership
        • 7.3.5.2.2. By Type of Dialysis
        • 7.3.5.2.3. By Service

8. Asia Pacific Dialysis Center Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Ownership
    • 8.2.2. By Type of Dialysis
    • 8.2.3. By Service
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Dialysis Center Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Ownership
        • 8.3.1.2.2. By Type of Dialysis
        • 8.3.1.2.3. By Service
    • 8.3.2. India Dialysis Center Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Ownership
        • 8.3.2.2.2. By Type of Dialysis
        • 8.3.2.2.3. By Service
    • 8.3.3. Japan Dialysis Center Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Ownership
        • 8.3.3.2.2. By Type of Dialysis
        • 8.3.3.2.3. By Service
    • 8.3.4. South Korea Dialysis Center Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Ownership
        • 8.3.4.2.2. By Type of Dialysis
        • 8.3.4.2.3. By Service
    • 8.3.5. Australia Dialysis Center Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Ownership
        • 8.3.5.2.2. By Type of Dialysis
        • 8.3.5.2.3. By Service

9. Middle East & Africa Dialysis Center Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Ownership
    • 9.2.2. By Type of Dialysis
    • 9.2.3. By Service
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Dialysis Center Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Ownership
        • 9.3.1.2.2. By Type of Dialysis
        • 9.3.1.2.3. By Service
    • 9.3.2. UAE Dialysis Center Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Ownership
        • 9.3.2.2.2. By Type of Dialysis
        • 9.3.2.2.3. By Service
    • 9.3.3. South Africa Dialysis Center Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Ownership
        • 9.3.3.2.2. By Type of Dialysis
        • 9.3.3.2.3. By Service

10. South America Dialysis Center Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Ownership
    • 10.2.2. By Type of Dialysis
    • 10.2.3. By Service
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Dialysis Center Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Ownership
        • 10.3.1.2.2. By Type of Dialysis
        • 10.3.1.2.3. By Service
    • 10.3.2. Colombia Dialysis Center Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Ownership
        • 10.3.2.2.2. By Type of Dialysis
        • 10.3.2.2.3. By Service
    • 10.3.3. Argentina Dialysis Center Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Ownership
        • 10.3.3.2.2. By Type of Dialysis
        • 10.3.3.2.3. By Service

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Dialysis Center Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Fresenius Medical Care AG & Co. KGaA
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. DaVita Inc.
  • 15.3. Baxter International Inc.
  • 15.4. B. Braun Melsungen AG
  • 15.5. Nipro Corporation
  • 15.6. Renal Ventures Management, LLC
  • 15.7. U.S. Renal Care, Inc.
  • 15.8. Dialysis Clinics, Inc.
  • 15.9. MEDICARE Health Partners
  • 15.10. Asahi Kasei Corporation

16. Strategic Recommendations

17. About Us & Disclaimer